|
1
|
Tindall WN, Boltri JM and Wilhelm SM:
Mild-to-moderate ulcerative colitis: Your role in patient
compliance and health care costs. J Manag Care Pharm. 13((7 Suppl
A)): S2–S12; quiz S13-S14. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
International Agency for Research on
Cancer (IARC): Cancer Tomorrow. Estimated number of incident cases
from 2018 to. 2040, colon both sexes, all ages. IARC, Lyon, 2018.
http://gco.iarc.fr/tomorrow/graphic-line?type=0&population=900&mode=population&sex=0&cancer=39&age_group=value&apc_male=0&apc_female=0.
|
|
3
|
Farraye FA, Odze RD, Eaden J, Itzkowitz
SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T III,
McLeod R, et al: AGA medical position statement on the diagnosis
and management of colorectal neoplasia in inflammatory bowel
disease. Gastroenterology. 138:738–745. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tranter-Entwistle I, Mullaney TG, Noah K,
Pearson J, Falvey J, Gearry R and Eglinton T: Long-term incidence
of dysplasia and colorectal cancer in an ulcerative colitis
population-based cohort. ANZ J Surg: Jan 23, 2020 (Epub ahead of
print).
|
|
5
|
Sartor RB: Mechanisms of disease:
Pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin
Pract Gastroenterol Hepatol. 3:390–407. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dorofeyev AE, Vasilenko IV, Rassokhina OA
and Kondratiuk RB: Mucosal barrier in ulcerative colitis and
Crohn's disease. Gastroenterol Res Pract.
2013(431231)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kawashima H: Roles of the gel-forming MUC2
mucin and its O-glycosylation in the protection against colitis and
colorectal cancer. Biol Pharm Bull. 35:1637–1641. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Okumura R, Kurakawa T, Nakano T, Kayama H,
Kinoshita M, Motooka D, Gotoh K, Kimura T, Kamiyama N, Kusu T, et
al: Lypd8 promotes the segregation of flagellated microbiota and
colonic epithelia. Nature. 532:117–121. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Garrett WS, Gallini CA, Yatsunenko T,
Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L,
Glickman JN, et al: Enterobacteriaceae act in concert with the gut
microbiota to induce spontaneous maternally transmitted colitis.
Cell Host Microbe. 8:292–300. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mukhopadhya I, Hansen R, El-Omar EM and
Hold GL: IBD-what role do Proteobacteria play? Nat Rev
Gastroenterol Hepatol. 9:219–230. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hansen R, Thomson JM, Fox JG, El-Omar EM
and Hold GL: Could Helicobacter organisms cause inflammatory bowel
disease? FEMS Immunol Med Microbiol. 61:1–14. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pearl DS, Shah K, Whittaker MA,
Nitch-Smith H, Brown JF, Shute JK and Trebble TM: Cytokine mucosal
expression in ulcerative colitis, the relationship between cytokine
release and disease activity. J Crohns Colitis. 7:481–489.
2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tytgat KM, van der Wal JW, Einerhand AW,
Büller HA and Dekker J: Quantitative analysis of MUC2 synthesis in
ulcerative colitis. Biochem Biophys Res Commun. 224:397–405.
1966.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Matts SG: The value of rectal biopsy in
the diagnosis of ulcerative colitis. Q J Med. 30:393–407.
1961.PubMed/NCBI
|
|
15
|
World Medical Association: World medical
association declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA 310: 2191.2194, 2013.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bruno ME, Rogier EW, Arsenescu RI,
Flomenhoft DR, Kurkjian CJ, Ellis GI and Kaetzel CS: Correlation of
biomarker expression in colonic mucosa with disease phenotype in
Crohn's disease and ulcerative colitis. Dig Dis Sci. 60:2976–2984.
2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lin X, Li J, Zhao Q, Feng JR, Gao Q and
Nie JY: WGCNA reveals key roles of IL8 and MMP-9 in progression of
involvement area in colon of patients with ulcerative colitis. Curr
Med Sci. 38:252–258. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Korolkova OY, Myers JN, Pellom ST, Wang L
and M'Koma AE: Characterization of serum cytokine profile in
predominantly colonic inflammatory bowel disease to delineate
ulcerative and Crohn's colitides. Clin Med Insights Gastroenterol.
8:29–44. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mazzucchelli L, Hauser C, Zgraggen K,
Wagner H, Hess M, Laissue JA and Mueller C: Expression of
interleukin-8 gene in inflammatory bowel disease is related to the
histological grade of active inflammation. Am J Pathol.
144:997–1007. 1994.PubMed/NCBI
|
|
21
|
Dkhil MA: Sex-determined susceptibility
and differential MUC2 mRNA expression during the course of murine
intestinal eimeriosis. Parasitol Res. 114:283–288. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Niv Y: Mucin gene expression in the
intestine of ulcerative colitis patients: A systematic review and
meta-analysis. Eur J Gastroenterol Hepatol. 28:1241–1245.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Neurath MF and Travis SP: Mucosal healing
in inflammatory bowel diseases: A systematic review. Gut.
61:1619–1635. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Papi C and Aratari A: Mucosal healing as a
treatment for IBD? Expert Rev Gastroenterol Hepatol. 8:457–459.
2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shah SC, Colombel JF, Sands BE and Narula
N: Mucosal healing is associated with improved long-term outcomes
of patients with ulcerative colitis: A systematic review and
meta-analysis. Clin Gastroenterol Hepatol. 14:1245–1255.e8.
2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
D'Haens G, Sandborn WJ, Feagan BG, Geboes
K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P,
Schölmerich J and Sutherland LR: A review of activity indices and
efficacy end points for clinical trials of medical therapy in
adults with ulcerative colitis. Gastroenterology. 132:763–786.
2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rosenberg L, Nanda KS, Zenlea T, Gifford
A, Lawlor GO, Falchuk KR, Wolf JL, Cheifetz AS, Goldsmith JD and
Moss AC: Histologic markers of inflammation in patients with
ulcerative colitis in clinical remission. Clin Gastroenterol
Hepatol. 11:991–996. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mazzuoli S, Guglielmi FW, Antonelli E,
Salemme M, Bassotti G and Villanacci V: Definition and evaluation
of mucosal healing in clinical practice. Dig Liver Dis. 45:969–977.
2013.PubMed/NCBI View Article : Google Scholar
|
